Pericapsular Solution Composition and Injection Site
A pericapsular solution typically contains a local anesthetic (such as bupivacaine or ropivacaine) combined with a corticosteroid, and is injected around the joint capsule rather than directly into the joint space itself. 1
Solution Components
The pericapsular injection solution generally includes:
- Local anesthetic: Commonly bupivacaine, lidocaine (lignocaine), or mepivacaine at concentrations of 0.5-1% 1, 2
- Corticosteroid: Methylprednisolone (40-80 mg for large joints), triamcinolone acetonide (40-80 mg), or similar long-acting corticosteroid preparations 3, 2
- Total volume: Typically 4.5-5 ml for adequate distribution around the capsule 1, 4
Injection Location
Pericapsular injections are administered into the tissues surrounding the joint capsule, not into the intra-articular space. 1 This distinguishes them from intra-articular injections, which target the joint cavity itself.
Key Anatomical Considerations:
- For hip joints: The injection is placed around the hip capsule, often targeting the pericapsular nerve group (PENG) region, which lies between the psoas tendon and the pubic ramus 5
- For knee joints: Pericapsular injections target the soft tissues and nerve structures around the joint capsule 1
- For sacroiliac joints: The solution is delivered around the SI joint capsule when intra-articular access is challenging 4
Clinical Context and Efficacy
Important distinction: The evidence base strongly favors intra-articular over pericapsular injections for osteoarthritis pain management. 6, 7
- Intra-articular corticosteroid injections are recommended by major guidelines (VA/DoD 2020, EULAR 2017) for persistent knee and hip OA pain 6, 8
- Pericapsular injections showed equivalent results to intra-articular injections in one study, but this is not the standard approach 1
- For hip OA specifically, intra-articular triamcinolone (80 mg) provided significant pain relief at 3 and 12 weeks, while local anesthetic alone (pericapsular) showed no significant benefit 2
Evidence Comparison:
A critical study by Lilius et al. randomized 109 patients into three groups: intra-articular corticosteroid + anesthetic, pericapsular corticosteroid + anesthetic, and intra-articular saline. While both active treatment groups showed some benefit, the study design suggests pericapsular administration may have limited efficacy compared to intra-articular delivery. 1
Technical Administration
Ultrasound or fluoroscopic guidance is strongly recommended, particularly for hip injections, to ensure accurate placement and avoid inadvertent intra-articular or intravascular injection. 7, 8
- Strict aseptic technique is mandatory 3
- The suspension should be shaken before use and injected without delay to prevent settling 3
- Care must be taken to avoid injecting into surrounding tissues, which may cause tissue atrophy 3
Clinical Caveat
For osteoarthritis-related joint pain, intra-articular injection remains the evidence-based standard, not pericapsular injection. 6, 8 Pericapsular approaches are primarily used for:
- Nerve blocks for perioperative analgesia (e.g., PENG block for hip surgery) 9, 5
- Cases where intra-articular access is technically difficult 4
- Specific pain syndromes involving pericapsular structures rather than the joint itself 1
The emerging use of pericapsular nerve group (PENG) blocks with local anesthetic alone (without corticosteroid) shows promise for chronic hip pain, but this represents a different therapeutic approach focused on nerve blockade rather than anti-inflammatory effects. 5